Skip to content
Fundamental Analysis

When a regulator sets the price

A large part of the Indian market sells at prices fixed by statute or by a regulator. The ceiling, the revision cycle and the consultation papers are all public documents.

Fundamental AnalysisIntermediate13 min read
Browse Fundamental Analysis(169)

Most analysis of pricing asks whether a company can make a price increase stick — whether the brand is strong enough, whether the customer has an alternative. For a substantial part of the Indian market the question does not arise, because the maximum price is fixed by a government order and exceeding it is an offence. The company's competitive strength is simply irrelevant to what it may charge, and the single largest driver of its realisation can be read from a public notification rather than estimated.

Think of it like this
The government bus fare

A state transport bus cannot charge more on a crowded route than on an empty one, because the fare per kilometre is set by an order in a file in the transport department. A private operator on the same road charges what the day allows. Both are running buses; only one is running a pricing decision.

In the market

A company selling a scheduled formulation or a regulated transmission service is the state bus. Demand, brand and bargaining power move volumes and costs, but the ceiling on price is set elsewhere, and it moves when an order says it moves.

The three big regimes

SectorWho sets the priceOn what basis
PharmaceuticalsThe National Pharmaceutical Pricing Authority, under the Drug Price Control Order, 2013A ceiling price for formulations listed in the National List of Essential Medicines, revised annually against the wholesale price index
Electricity generation and transmissionThe Central Electricity Regulatory Commission for inter-state assets; the state commission otherwiseA tariff order allowing a return on equity plus recovery of approved costs, set for a multi-year control period
Electricity distributionThe state electricity regulatory commissionAn annual revenue requirement and a retail tariff order, with any shortfall carried as a regulatory asset
TelecomThe Telecom Regulatory Authority of IndiaLargely forbearance on retail tariffs, but interconnection charges and broadcasting tariff orders are fixed by regulation
Fertiliser and sugarThe central government, through the relevant ministryStatutorily controlled retail prices and subsidy rates on one side; a fixed minimum cane price on the input side

How a drug ceiling price is actually computed

Under the Drug Price Control Order, 2013, formulations that appear in the National List of Essential Medicines are scheduled. For each of them the ceiling price is derived from the simple average of the price to retailer of all brands having at least a one per cent share of that formulation's market, plus a notified retailer margin of 16%. It is a market-based average, not a cost-plus calculation, and it is published as an order that names the formulation, the strength and the rupee ceiling.

Worked example
What a ceiling revision does to a product line
An illustrative scheduled formulation
Existing ceiling priceNotified by the NPPA for that formulation and strength₹9.80 per tablet
Company's current realisationAlready close to the ceiling, as most brands end up being₹9.60 per tablet
Annual revision basisParagraph 16 of the DPCO permits an annual revision on this basisWholesale price index for the preceding calendar year
Illustrative WPI changeThe published index number, not a negotiated figure+1.7%
Revised ceilingWhich is the maximum, not an entitlement₹9.97 per tablet
Input cost change over the same yearWhich the ceiling formula does not considerActive ingredient up 9%
For a scheduled product the price revision is bounded by an index that has nothing to do with the company's own costs. That asymmetry — an input market that moves freely against an output price that moves on a published index — is the structural feature of price control, and it is why gross margin on scheduled formulations behaves differently from margin on the same company's unscheduled ones.

Regulated utilities: a return, not a price

Electricity regulation works differently. Instead of capping the price of a unit, the commission determines what revenue the asset is allowed to earn, builds it from approved capital cost, depreciation, operations and maintenance, interest and a specified return on equity, and then sets a tariff that recovers it. The Central Electricity Regulatory Commission's tariff regulations have used a base return on equity of 15.5% for generation and transmission, with additional incentives for meeting normative availability and timely commissioning.

  • The control period is stated. Tariff regulations run for a multi-year block, and the draft regulations, the objections filed and the final order are all published on the commission's website. The next revision is on a known calendar, and the consultation that will shape it happens in public first.
  • The risk shifts from price to allowance. A regulated transmission asset does not face demand risk in the ordinary sense; it faces the risk that the regulator disallows a cost, reduces the permitted return, or tightens the availability norm.
  • Recovery is not the same as revenue. A distribution company may be allowed a revenue requirement it cannot actually collect at the approved retail tariff. The uncollected difference is carried as a regulatory asset — an amount recognised now against tariffs a future order is expected to permit.
  • Read the order, not the summary. The tariff order names the asset, the approved capital cost, the disallowances and the reasons. It is the single most informative document about a regulated utility, and it is free.
  • Regulatory lag is a real cost. Between an input cost rising and a tariff order recognising it, the company funds the gap. In a period of sharply rising fuel or interest costs, that lag is where the margin goes.

The squeeze that comes from both ends

The hardest version is a business where the state fixes the input price and influences the output price at the same time. Sugar mills must pay the fair and remunerative price for cane, fixed by the central government on the recommendation of the Commission for Agricultural Costs and Prices, with several states declaring a higher state advised price on top. On the output side the centre sets a minimum selling price below which a mill may not sell sugar; it was fixed at ₹31 per kilogram in February 2019 and changes only when a fresh order says so, which is why the current figure is worth checking against the latest notification rather than a secondary source. Neither side of the margin is negotiated between a buyer and a seller, and the mill's profitability is largely a function of two administrative decisions taken in different places.

Check yourself

A pharmaceutical company earns 55% of revenue from formulations in the National List of Essential Medicines. Its active ingredient cost rose 9% during the year. What does the price-control regime imply about its pricing response?

◆ Checkpoint

Module checkpoint: rules that set the numbers

5 questions. Answers are revealed once you submit all of them.

1.What is the practical difference between net profit and total comprehensive income?

2.Why does a PLI incentive booked in other operating income matter more than a concessional tax rate?

3.What does the Schedule III trade payables ageing schedule add that the balance sheet does not?

4.When do anchor investor lock-ins expire under the current SEBI ICDR Regulations?

5.Under the Drug Price Control Order, 2013, how is the ceiling price of a scheduled formulation determined?

0 of 5 answered
Simple bhasha mein
Sarkari bus ka kiraya

Sarkari bus bheed wale route pe bhi zyada kiraya nahi le sakti — per kilometre rate transport department ki file mein tay hai. Usi sadak pe private wala jo din chale wahi leta hai. Dono bus chala rahe hain; pricing sirf ek kar raha hai. Scheduled dawa ya transmission line wali company sarkari bus hai — ceiling notification badalne pe hi badalta hai, company ki laagat badhne pe nahi.

What to remember
  • A scheduled drug's ceiling is a market average plus 16%, revised on the wholesale price index.
  • Non-scheduled formulations still face a 10% annual increase limit under the DPCO.
  • Utility regulation fixes an allowed return and a control period, not a unit price.
  • Regulatory lag and regulatory assets are where a utility's margin actually goes.
  • Under price control the levers left are cost position, mix and volume, not pricing power.

Common questions

Short, direct answers to what people ask about this topic.

dpco meaning in pharma
DPCO is the Drug Price Control Order, 2013, the order under which the National Pharmaceutical Pricing Authority fixes the maximum price of medicines in India. Formulations listed in the National List of Essential Medicines are scheduled and carry a notified ceiling price; non-scheduled formulations may be priced freely but cannot be increased by more than 10% in any twelve months. Selling above a notified ceiling is an offence, so for a scheduled product a company’s brand strength has no bearing on what it may charge.
how is the ceiling price of a scheduled drug calculated
It is the simple average of the price to retailer of all brands having at least a one per cent share of that formulation’s market, plus a notified retailer margin of 16%. That makes it a market-based average rather than a cost-plus calculation, so a manufacturer’s own input cost inflation has no bearing on the permitted ceiling. Paragraph 16 of the DPCO permits an annual revision against the wholesale price index, and the result is published as an order naming the formulation, the strength and the rupee ceiling.
the maximum price at which a scheduled formulation may be sold is called the
Ceiling price. It is notified by the National Pharmaceutical Pricing Authority for each scheduled formulation and strength, and it is a maximum rather than an entitlement — most brands end up realising close to it, but nothing obliges them to. Exceeding a notified ceiling is an offence under the Drug Price Control Order, 2013.
how much can a non-scheduled drug price be increased in a year
10% in any twelve months, under paragraph 20 of the Drug Price Control Order, 2013. So even the part of the Indian pharmaceutical market outside direct price control carries a statutory speed limit on price increases. Paragraph 19 separately lets the NPPA fix the price of any drug or device in the public interest in extraordinary circumstances — the power used to cap coronary stent prices in February 2017 and knee implant prices in August 2017.
what return on equity does CERC allow for transmission projects
The Central Electricity Regulatory Commission’s tariff regulations have used a base return on equity of 15.5% for generation and transmission, with additional incentives for meeting normative availability and timely commissioning. The commission does not cap the price of a unit — it determines the revenue an asset is allowed to earn from approved capital cost, depreciation, operations and maintenance, interest and that return, then sets a tariff to recover it. The base rate is set in regulations that run for a multi-year control period, so check the ones in force for the period you are reading.